- Q3 net sales $2.2M flat YoY, up 12% sequentially
- Operating loss $2.1M, improved 24% YoY
- Gross margin 69.5% vs 65.2%
Nuwellis Q3 operating loss narrowed 24% to $2.1M on margin expansion and cost cuts. Console sales nearly doubled YTD. FDA submission seeks pediatric label expansion.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.